This text is a result of machine translation.
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Putin will soon visit Central Asia and attend the Caspian summit, which is the first visit since the conflict between Russia and Ukraine
China Evergrande: it is expected to announce the preliminary restructuring plan at the end of July
Tianci materials: it is planned to buy back the company's shares of RMB 250million to RMB 500million
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Evergrande real estate was enforced for another 4.183 billion yuan
Lithium battery stocks continued to strengthen, and Edison raised the sealing plate
The Real Bottleneck in Embodied AI: Not Just AI, but Scenarios
Apr 07, 2026 06:52 PM
Investment Is Booming, Orders Are Rising, but Robots Are Still Learning How to Deliver
Mar 23, 2026 10:29 AM
Thinking of ASEAN as a single market is the biggest miscalculation for Chinese companies
Feb 19, 2026 12:00 PM